Literature DB >> 23867859

Treatment options for visceral artery aneurysms: ten year experience.

D Mazzaccaro1, M Carmo, G Nano, I Barbetta, A M Settembrini, M T Occhiuto, S Stegher, R Dallatana, G Malacrida, P G Settembrini.   

Abstract

AIM: Open surgical repair (OSR) and endovascular techniques (ET) are both described in the literature for treating visceral artery aneurysms (VAAs). Aim of this study is to report a two-center experience of patients treated for a VAA using either OSR or ET, analyzing perioperative outcomes.
METHODS: Clinical data of 32 VAAs in 32 patients treated between January 2001 and May 2011 were retrospectively reviewed and outcomes analyzed.
RESULTS: Eighteen patients were men (56.3%). Median age was 64 years (range 26-79). Sixteen aneurysms were symptomatic: half of them were ruptured causing hemoperitoneum or gastrointestinal bleeding. ET were employed in 19 cases (59%) using covered stents (7 patients), coil embolization (5), plug placement (1), thrombin injection (2) and multiple associated techniques (4). OSR consisted in aneurysmectomy with end to end anastomoses (5 patients) or interposition graft (1), aneurysm ligation (4), splenectomy (2). One patient died during open surgery for hemoperitoneum due to VAA rupture (3%). OSR and ET had similar perioperative complication rates (5.2% vs. 15.3%, P=0.76). OSR had a longer in-hospital stay than ET (8 vs. 4 days, P=0.04). The presence of pancreatitis and alcohol abuse were more frequent in patients who presented with VAAs rupture. Clinical presentation with hemoperitoneum or aneurysm rupture were associated with higher mortality, regardless of the type of treatment.
CONCLUSION: Both OSR and ET offered a safe way to treat VAAs in our experience.

Entities:  

Mesh:

Year:  2013        PMID: 23867859

Source DB:  PubMed          Journal:  J Cardiovasc Surg (Torino)        ISSN: 0021-9509            Impact factor:   1.888


  1 in total

1.  Multiple visceral artery aneurysms managed by Yasargil aneurysm clips.

Authors:  In-Kee Hong; Ji-Ho Choi; Young Chae Chu; Yong Sun Jeon; Keon-Young Lee
Journal:  Ann Surg Treat Res       Date:  2015-08-24       Impact factor: 1.859

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.